首页> 外文期刊>The aging male: the official journal of the International Society for the Study of the Aging Male >Testosterone replacement therapy and cardiovascular risk factors modification.
【24h】

Testosterone replacement therapy and cardiovascular risk factors modification.

机译:睾丸激素替代疗法和心血管危险因素的修改。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypogonadism in males is associated with increased atherosclerotic disease. Physiologically, testosterone appears to have both positive and negative effects on the cardiovascular system. Testosterone decreases angina and may improve the cardiac healing response after myocardial infarction. Testosterone enhances function in males with heart failure (HF). Testosterone causes water retention and oedema is common in older persons. Oedema should not be used to diagnose HF in older persons. Studies in older persons with HF and frailty have shown a non-statistically lower mortality rate compared to those receiving placebo.
机译:男性性腺机能减退与动脉粥样硬化疾病增加有关。在生理上,睾丸激素似乎对心血管系统有正面和负面影响。睾丸激素可减少心绞痛,并可改善心肌梗塞后的心脏愈合反应。睾丸激素可增强患有心力衰竭(HF)的男性的功能。睾丸激素会导致水分滞留,水肿在老年人中很常见。不应将水肿用于诊断老年人的心力衰竭。对患有HF和体弱的老年人的研究表明,与接受安慰剂的人相比,死亡率没有统计学意义的降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号